Our Investment in Alpha-9 Oncology - generalcatalyst.com

Oct 23, 2024  · With this financing, Alpha-9 Oncology aims to support further clinical studies and advance their pipeline of radiopharmaceuticals. Our Health Assurance thesis is aligned with …


Install CouponFollow Chrome Extension   CouponFollow Extension

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 23, 2024  · BOSTON, Mass. and VANCOUVER, British Columbia, October 23, 2024 – Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing …

a9oncology.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed

4 weeks from now

Oct 24, 2024  · BOSTON and VANCOUVER, BC, Oct. 23, 2024 /PRNewswire/ -- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing …

biospace.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 23, 2024  · Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with …

yahoo.com

$175
OFF

Alpha-9 Oncology Secures $175M Series C To Drive …

4 weeks from now

Boston, MA and Vancouver, Canada, October 23, 2024 (PRNewswire) -- Alpha-9 Oncology has raised $175 million in Series C funding to advance its radiopharmaceutical pipeline for cancer …

jacobsmgt.com

$261
OFF

Alpha-9 Oncology - Raised $261M Funding From 15 Investors

4 weeks from now

6 days ago  · List of Alpha-9 Oncology's institutional investors. Lightspeed Venture Partners, located in Menlo Park (United States), made their first investment in Alpha-9 Oncology on Oct …

tracxn.com

$175
OFF

Radiopharma Startup Alpha-9 Nets $175M Series C

4 weeks from now

Oct 24, 2024  · The company says, “Each component is designed for optimal selectivity, stability and payload delivery. Alpha-9 approach is rigorous, fast and capital efficient, generating best …

insideprecisionmedicine.com

$75
OFF

Alpha-9 Theranostics Announces Oversubscribed $75 ... - Alpha-9 …

4 weeks from now

Dec 14, 2022  · Alpha-9 is advancing a robust pipeline of novel radiopharmaceuticals with a systematic approach to molecule design that offers broad potential for expansion into several …

a9oncology.com

$11
OFF

Alpha-9 Theranostics Announces $11 Million Series A ... - Alpha-9 …

4 weeks from now

Apr 28, 2021  · VANCOUVER, British Columbia, April 28, 2021 — Alpha-9 Theranostics Inc. announced today an $11 million Series A financing to advance a portfolio of novel …

a9oncology.com

$11
OFF

Alpha-9 Theranostics Announces $11 Million Series A Financing To ...

4 weeks from now

Apr 28, 2021  · VANCOUVER, British Columbia, April 28, 2021 (GLOBE NEWSWIRE) -- Alpha-9 Theranostics Inc. announced today an $11 million Series A financing to advance a portfolio of …

yahoo.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

BOSTON and VANCOUVER, BC, October 23, 2024-- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve …

vcaonline.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 24, 2024  · BOSTON, MA & VANCOUVER, BC – Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve …

lifesciencesbc.ca

FAQs about Our Investment in Alpha-9 Oncology - generalcatalyst.com Coupon?

Who is alpha-9 oncology?

BOSTON, Mass. and VANCOUVER, British Columbia, October 23, 2024 – Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, today announced an oversubscribed $175 million Series C financing to support the progression of its pipeline. ...

Why did alpha-9 announce a $175 million Series C financing?

BOSTON and VANCOUVER, BC, Oct. 23, 2024 /PRNewswire/ -- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, today announced an oversubscribed $175 million Series C financing to support the progression of its pipeline. ...

Is alpha-9 a good radiopharmaceutical company?

“Over the last few years, Alpha-9 has built a leading radiopharmaceutical company with a deep pipeline and robust infrastructure,” said Alpha-9 CEO, David Hirsch, MD, PhD. “The Series C is an exciting, significant milestone for us and will greatly accelerate our growth. ...

What is alpha-9 theranostics?

About Alpha-9 Theranostics Alpha-9 Theranostics is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment of people living with cancer. ...

Why should you invest in a series C of alpha-9?

Furthermore, the Series C will fund expanded R&D capabilities and continued investment in CMC and supply chain. “Over the last few years, Alpha-9 has built a leading radiopharmaceutical company with a deep pipeline and robust infrastructure,” said Alpha-9 CEO, David Hirsch, MD, PhD. ...

Who invested in alpha-9?

The round was led by Nextech Invest, with participation from Frazier Life Sciences, Samsara BioCapital and Quark Venture in addition to existing investors Longitude Capital and BVF Partners. Alpha-9 is engineering highly effective, bespoke radiopharmaceuticals for the treatment of solid and hematologic malignancies. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension